Will Routine Therapeutic Drug Monitoring Have a Place in Clozapine Therapy?
- 1 February 1997
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 32 (2), 93-100
- https://doi.org/10.2165/00003088-199732020-00001
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Solid-Phase Extraction and High-Performance Liquid Chromtographic Analysis of Clozapine and Norclozapine in Human PlasmaTherapeutic Drug Monitoring, 1996
- Relation of leukocyte counts during clozapine treatment to serum concentrations of clozapine and metabolitesAmerican Journal of Psychiatry, 1995
- Metabolism and bioactivation of clozapine by human liver in vitro.1995
- Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patientsAmerican Journal of Psychiatry, 1995
- Measurement of clozapine and norclozapine in plasma/serum by high performance liquid chromatography with ultraviolet detectionBiomedical Chromatography, 1995
- Plasma clozapine and haloperidol concentrations in adolescents with childhood-onset schizophrenia: association with response.1994
- Clozapine‐related seizuresNeurology, 1991
- Effect of phenytoin on plasma clozapine concentrations in two patients.1991
- Single- vs Multiple-Dose Pharmacokinetics of Clozapine in Psychiatric PatientsPharmaceutical Research, 1990
- Clozapine for the Treatment-Resistant SchizophrenicArchives of General Psychiatry, 1988